[Cardiomyopathy and ion channel diseases registry: the Szeged CardioGen Registry].
Blazsó. Péter P; Kákonyi. Kornél K; Forster. Tamás T; Sepp. Róbert R
Key Findings
- The registry includes the main types of primary cardiomyopathies and several ion channel diseases.
- Hypertrophic cardiomyopathy is the most common condition in the registry (388 patients).
- Dilated cardiomyopathy (310 patients) and long QT syndrome (111 patients) are the next largest groups.
Practical Outcomes
- For self‑directed health optimizers, this abstract offers no new treatment tips, dosage guidance, or actionable protocols. It simply provides epidemiological data that may be of interest for understanding disease prevalence, but it does not inform any practical steps for longevity, metabolic health, or performance enhancement.
Summary
The Szeged CardioGen Registry is a database that collects information on patients with various heart muscle diseases and electrical heart disorders. It mainly reports how many people have each condition and notes that the data for hypertrophic cardiomyopathy patients look similar to what other studies have found.
Abstract
The Szeged cardiomyopathy and ion channel diseases registry aims to establish a representative disease-specific registry based on the recruitment of patients with different cardiomyopathies and ion channel diseases followed at the Cardiology Center, University of Szeged. The registry collects patient data on the main forms of primary cardiomyopathies (hypertrophic, dilated, restrictive, arrhythmogenic right ventricular, left ventricular non-compact, tako-tsubo cardiomyopathy) and ion channel diseases (long QT syndrome, short QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia). Patients with hypertrophic cardiomyopathy (388 patients) make up the largest group of patients in the registry. Patients with dilated cardiomyopathy (310 patients) and patients with the long QT syndrome (111 patients) form two other sizable groups. Analyzed data of the group of patients with hypertrophic cardiomyopathy indicate similar figures with regard to disease related mortality and morbidity and clinical parameters. Orv. Hetil., 2017, 158(3), 101-105.
Study Information
pubmed
2017
10.1556/650.2017.30659
1
7